ClearPoint Neuro, Inc. (CLPT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ClearPoint Neuro, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -15.17x | -21.98x | -7.56x | -12.46x | -16.14x | -37.14x |
| P/B Ratio | 13.82x | 16.37x | 7.89x | 5.55x | 4.77x | 105.95x |
| P/S Ratio | 10.48x | 13.24x | 6.97x | 9.97x | 14.27x | 19.63x |
| Profitability | ||||||
| Gross Margin | 61.4% | 60.9% | 56.8% | 65.8% | 68.2% | 71.1% |
| Operating Margin | -65.4% | -62.9% | -93.7% | -79.5% | -82.1% | -48.5% |
| Net Margin | -69.1% | -60.3% | -92.2% | -80.0% | -88.4% | -52.9% |
| EBITDA Margin | -59.3% | -56.8% | -87.6% | -75.8% | -78.2% | -37.3% |
| Liquidity | ||||||
| Current Ratio | 5.91x | 3.22x | 4.87x | 7.54x | 13.02x | 7.96x |
| Quick Ratio | 5.13x | 2.56x | 3.80x | 6.17x | 11.98x | 6.95x |
| Leverage | ||||||
| Debt/Equity | 2.08x | 0.14x | 0.66x | 0.32x | 0.25x | 10.15x |
YoY = year-over-year change. Source: FMP..